A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

Shares of Maze Therapeutics rose nearly 1% in their Nasdaq debut on Friday, valuing the kidney disease drug developer at $690.37 million.

Non-resident property transactions in India face compliance challenges, including obtaining TAN, depositing TDS, and filing e ...

Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

The casual-dining chain’s 31% same-store sales number was shocking by any standard, and stands up to some of the best ...

All Points North explores why foreign nationals may face job discrimination in Finland and looks at measures to improve ...

Learn how to create a dynamic reports in Excel using one formula. Simplify calculations and automate your workflow ...

The political landscape of the Euro Area is complex, encompassing 20 EU members, it isn't a single nation. It's a monetary union, meaning a unique, multi-layered governance structure is at play. Each ...

A small-scale homeless outreach program that Mayor Adams’ administration launched in late 2022 has proven effective. But the ...

Rumors of ICE raids in the first week of Trump's presidency rattled a community that's been preparing for the his promise of ...

The IPO comes amid a deregulatory push in the energy sector by President Donald Trump, who repeated the "drill, baby, drill" slogan in his inaugural address. Earlier this week, Sean Duffy, the newly ...